CVS vs IONS · P/E 16, rev $402.07B vs rev $226.6M
CVS Health Corp (CVS) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. IONS currently screens at market cap $12.28B.
Not investment advice. Open the CVS and IONS stock pages for the full models.
Not investment advice.